Yüklüyor......
Can Arginase Inhibitors Be the Answer to Therapeutic Challenges in Alzheimer’s Disease?
While the extensive hunt for therapeutics combating Alzheimer’s disease (AD) has fallen short of delivering effective treatments, breakthroughs towards understanding the disease mechanisms and identifying areas for future research have nevertheless been enabled. The majority of clinical trials with...
Kaydedildi:
| Yayımlandı: | Neurotherapeutics |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Springer International Publishing
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6277284/ https://ncbi.nlm.nih.gov/pubmed/30242774 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-018-0668-6 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|